Belite Bio, Inc Capital Expenditures
Belite Bio, Inc (BLTE) reported Capital Expenditures of $71.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-31
| Period end | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|
| 2025-12-31 | $71.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $116.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $63.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $394.00K 20-F · filed 2025-03-17 |
| 2021-12-31 | $74.00K 20-F · filed 2024-03-12 |